Wang Shuo - Net Worth and Insider Trading

Wang Shuo Net Worth

The estimated net worth of Wang Shuo is at least $23 Million dollars as of 2024-06-24. Wang Shuo is the Securities Affairs Representative of Shenyang Xingqi Pharmaceutical Co Ltd and owns about 137,200 shares of Shenyang Xingqi Pharmaceutical Co Ltd (SZSE:300573) stock worth over $23 Million. Details can be seen in Wang Shuo's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Wang Shuo has not made any transactions after 2020-05-13 and currently still holds the listed stock(s).

Transaction Summary of Wang Shuo

To

Wang Shuo Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Wang Shuo owns 1 companies in total, including Shenyang Xingqi Pharmaceutical Co Ltd (SZSE:300573) .

Click here to see the complete history of Wang Shuo’s form 4 insider trades.

Insider Ownership Summary of Wang Shuo

Ticker Comapny Transaction Date Type of Owner
SZSE:300573 Shenyang Xingqi Pharmaceutical Co Ltd 2020-05-13 Securities Affairs Representative

Wang Shuo Latest Holdings Summary

Wang Shuo currently owns a total of 1 stock. Wang Shuo owns 137,200 shares of Shenyang Xingqi Pharmaceutical Co Ltd (SZSE:300573) as of May 13, 2020, with a value of $23 Million.

Latest Holdings of Wang Shuo

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
SZSE:300573 Shenyang Xingqi Pharmaceutical Co Ltd 2020-05-13 137,200 171.18 23,485,896

Holding Weightings of Wang Shuo


Wang Shuo Form 4 Trading Tracker

According to the SEC Form 4 filings, Wang Shuo has made a total of 1 transactions in Shenyang Xingqi Pharmaceutical Co Ltd (SZSE:300573) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Shenyang Xingqi Pharmaceutical Co Ltd is the sale of 58,800 shares on May 13, 2020, which brought Wang Shuo around $3 Million.

Insider Trading History of Wang Shuo

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Wang Shuo Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Wang Shuo Ownership Network

Ownership Network List of Wang Shuo

No Data

Ownership Network Relation of Wang Shuo

Insider Network Chart

Wang Shuo Owned Company Details

What does Shenyang Xingqi Pharmaceutical Co Ltd do?

Who are the key executives at Shenyang Xingqi Pharmaceutical Co Ltd?

Wang Shuo is the Securities Affairs Representative of Shenyang Xingqi Pharmaceutical Co Ltd. Other key executives at Shenyang Xingqi Pharmaceutical Co Ltd include Directors & executives Cheng Ya Nan , Directors & executives Gao E , and Directors & executives Liu Ji Dong .

Shenyang Xingqi Pharmaceutical Co Ltd (SZSE:300573) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Shenyang Xingqi Pharmaceutical Co Ltd (SZSE:300573) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Shenyang Xingqi Pharmaceutical Co Ltd (SZSE:300573) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Shenyang Xingqi Pharmaceutical Co Ltd (SZSE:300573)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Shenyang Xingqi Pharmaceutical Co Ltd Insider Transactions

No Available Data

Wang Shuo Mailing Address

Above is the net worth, insider trading, and ownership report for Wang Shuo. Currently GuruFocus does not have mailing address information for Wang Shuo.

Discussions on Wang Shuo

No discussions yet.